- Overview Press tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Overview
Overview
Overview
Overview
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- Overview Press tab for submenu items
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
- Overview Press tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
Overview
Overview
Overview
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Overview Press tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
Recent Press releases
View all -
News alerts
-
Analyst recognition
-
Events
-
Media kit
- Overview Press tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Overview
Overview
Overview
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
Industry
Life Sciences
This will open an overlay
Patient-centered Care Models Taking Center Stage in Life Sciences
Read how patient-centric care models and pharma innovation are ushering new trends in life sciences to improve patient outcomes and enrich lives.
Related Insights
Learn how an integrated approach to packaging, artwork, and labeling management can effectively and efficiently manage the process and improve pharma compliance.
White Paper
23 Dec 2024
At the TCS Pace Port™, leaders explored the immense potential of AI and generative AI in the pharma industry during the Life Sciences Forum event. Learn more.
Article
02 Dec 2024
With EU MDR’s deadline extension, medtech manufacturers can leverage next-gen technologies and build on connected, collaborative, and cognitive value chains.
White Paper
29 Nov 2024
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
This paper highlights challenges in data transfer agreement and demonstrates how the proposed e-DTA solution can transform the clinical trial industry.
White Paper
18 Dec 2024
Engage with our experts at the World Drug Safety Congress Americas 2024 to learn about AI in pharmacovigilance and our TCS ADD™ Safety platform. Join us now.
Events
09 Sep 2024
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
Clinical trials can shift to a better operating model based on dynamic approaches for monitoring studies, as well as sites and study participants.
The life sciences sector is at a unique inflection point. Advancements in medicine and emerging demands have opened new, potential markets. However, the absence of a centralized information repository with data present in diverse systems and formats and reliance on human memory in selecting clinical trial sites and the execution process impedes market deployment. There is a prevalent need for a data science-led solution that leverages next-generation technologies such as AI/ML to provide predictive use cases, like adaptive monitoring for quicker data-driven decisions and greater market success.
The pharma and contract research organizations (CRO) are facing multiple challenges and inefficiencies due to predetermined and fixed schedules of site monitoring. The COVID-19 pandemic and the disruptions caused by it have forced organizations to reimagine how they engage with and support investigator sites. Traditional site monitoring methods use lagging indicators that leverage historical data and fail to provide an accurate assessment of site performance. Manual and time-intensive resource allocation and planning add to the overall workload and inefficiencies.
The following paper details the utilization of AI (artificial intelligence)- based algorithms to assess participating site performance and perform predictive analytics for identifying site workload and site risks. Additionally, it discusses about key risk indicators (KRI) and key performance indicators (KPI) for clinical research professionals at the sponsor organization. It also describes how clinical operations can shift to a better operating model based on dynamic monitoring of clinical trials, sites, and study participants.
Please visit the page below to read the paper:
Swipe LeftSwipe RightLeveraging next-gen technologies such as artificial intelligence and machine learning can empower sponsors to make data-driven decisions in an expedited manner. When you actually use artificial intelligence to predict site and risk workload, this proactive and predictive approach clearly augments the way and empowers end users to perform effective site monitoring. This, in turn, can be instrumental in bringing drugs faster to the patients in need.”
SAURABH DAS
Head, TCS ADD™ Analytics and Insights, TCS
About the authors
Image of Saurabh Das
Saurabh Das
Saurabh Das is part of Life Sciences, TCS ADD™. He has over 17 years of experience in product development and managing large program executions.
Image of Krishna Priya V K
Krishna Priya V K
Krishnapriya has been working in the field of big data implementation, data warehouse, and ETL tools for the last 15 years. She has played key roles in multiple system integration programs, migration programs, as well as modernization programs.
Image of Parul Dua
Parul Dua
Parul Dua has extensive industry experience in software design and development. Her area of expertise is web development and analytics.
© Copyright [2024], Tata Consultancy Services Limited. All Rights Reserved. Document ID CGTC010674
Related reading
Swipe Left
Swipe Right
Transformation starts here
Learn how we can help you bring drugs to the market faster.
Talk to our expertsFind out more
©2024 TATA Consultancy Services Limited
©2024 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
